Evotec SE (EVO) Non-Current Deffered Revenue (2020 - 2026)

Evotec SE's (EVO) quarterly Non-Current Deffered Revenue came in at $9031.1 in Q1 2026, down 70.54% year-on-year from $30660.3 in Q1 2025, and down 7.08% quarter-over-quarter from $9719.8 in Q4 2025.

Evotec SE (EVO) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends

Evotec SE has disclosed Non-Current Deffered Revenue across 7 years of filings, most recently posting $9031.1 for Q1 2026.

  • Non-Current Deffered Revenue for Q1 2026 came in at $9031.1, down 70.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $9031.1 (down 70.54% YoY), and the FY2025 annual result was $9719.8, down 99.97% from the prior year.
  • Non-Current Deffered Revenue came in at $9031.1 for Q1 2026 at Evotec SE, down from $9719.8 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $210.3 million in Q4 2022 to a low of -$205795.8 in Q2 2022.
  • The 5-year median for Non-Current Deffered Revenue is $15493.7 (2022), against an average of $34.2 million.
  • Across the five-year window, Non-Current Deffered Revenue surged 449.18% in 2022 and tumbled 99.97% in 2025, its largest moves.
  • Evotec SE's Non-Current Deffered Revenue stood at $210.3 million in 2022, then fell by 20.56% to $167.1 million in 2023, then sank by 80.46% to $32.7 million in 2024, then sank by 99.97% to $9719.8 in 2025, then dropped by 7.08% to $9031.1 in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $9031.1 (Q1 2026), $9719.8 (Q4 2025), and $10668.8 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Evotec SE 583.10 Mn 582.58 Mn - 9,031.13

Historic Data

Download Data
DateValue
Mar 31, 2026 9,031.13
Dec 31, 2025 9,719.76
Sep 30, 2025 10,668.80
Jun 30, 2025 31,697.14
Mar 31, 2025 30,660.33
Dec 31, 2024 32.65 Mn
Sep 30, 2024 9,569.88
Dec 31, 2023 167.08 Mn
Dec 31, 2022 210.31 Mn
Sep 30, 2022 14,695.60
Jun 30, 2022 -205,795.75
Mar 31, 2022 16,291.85
Dec 31, 2021 38.30 Mn
Sep 30, 2021 21,181.18
Dec 31, 2020 26.75 Mn